Skip to content

MassBio

Massachusetts Biotechnology Council

Open search form
  • Sign In/Create Account
  • Pay Company Dues
  • Become a Member
  • Resources
    • 2022 MA Life Sciences Workforce Analysis Report
    • 2021 Massachusetts Biopharma Funding Report
    • 2021 Industry Snapshot
    • 2021 State of Diversity, Equity, & Inclusion Report
    • Economic Development
    • Value of Health
    • Biopharma Startup Toolkit
    • Career Center
    • MassBioEd
  • Events
    • Events Calendar
    • Overview of Events
    • Get Involved
  • Membership
    • Member Directory
    • Benefits of Membership
    • Savings and Rewards
    • Member News
    • Become a Member
    • Member Rates
    • Pay Company Dues
  • Savings & Rewards
    • MassBioEdge
  • Conference Center
    • MassBioHub
  • Programs
    • State of Possible 2025 Report
    • Diversity, Equity, and Inclusion
    • Policy & Advocacy
    • Partnering Week 2022
    • Partnering Opportunities
    • MassBioDrive
    • Digital Health
    • BioReady Communities
  • About Us
    • About Us
    • News & Thought Leadership
    • Sponsorship Opportunities
    • Staff
    • Board of Directors
    • FAQs
    • Contact Us
  • Sign In/Create Account
  • Pay Company Dues
  • Become a Member
Open search form

Member Directory

Click to Open Main Menu

Leukocare Inc.

Life Sciences | Drug Development
Milford, MA Website

Overview

Leukocare Inc. is a biotechnology company specialized in the field of biopharmaceutical formulation
development. Operating at the interface of drug substance and drug product development, Leukocare
combines sound knowledge of formulation development with bioinformatics and artificial intelligence.
The formulation development approach consists of two elements: a library of up to 100 different
regulatory well-established and employed excipients and a rational development approach, which
employs statistical software and self-learning algorithms, as well as state of the art design of
experiment (DoE) matrices. By utilizing the artificial intelligence elements, Leukocare is able to
specifically combine excipients leading to stabilizing formulations tailored to the drug product’s needs.
Leukocare´s formulation technologies and expertise can be applied in the following core areas:

-Virus & Vaccines
-Biologics & Biosimilars
-Sterilization & Biofunctionalized Devices

Leukocare Inc. is a wholly owned subsidiary of Leukocare AG located in Martinsried/Munich, Germany.

Company News

News

Dr. Cornelius Pompe joined Leukocare as Vice President R&D; Dr. Sabine Hauck appointed as Senior Vice President Corporate Development

Aug 11, 2021

Posted by Leukocare Inc.

See all Members

Massachusetts Biotechnology Council

700 Technology Square, 5th Floor
Cambridge, MA 02139
617.674.5100

  • Contact
  • Privacy Policy
  • Fulfillment Policy
  • © 2022 All Rights Reserved